CompoAtlas

COLLMAR WOMAN

Food supplement declared in France, declaration No 2017-3-681, decision dated 17 March 2017

COLLMAR WOMAN (DRASANVI) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
DRASANVI
Food business operator placing the product on the market
DRASANVI
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Poudre
Daily dose
10 g
Directions for use
Prendre 10 g (2cuillères doseuses remplies à ras bord) dissous dans l´eau ou de jus.
Intended populations
Femme
Objectives stated by the manufacturer (these are not authorised claims)
Peau, Cheveux et ongles
Flavourings
GRENADE

Declaration 161534, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Other active ingredients

NamePer day
Collagène hydrolysénot declared
Acide hyaluroniquenot declared
Huile de graine de linnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-biotineBiotine (vitamine B8)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E162

Other ingredients

huile d'onagre, Jus de grenade

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Collagène hydrolysé
    Read the warning, when it applies and the studies cited

    Hydrolyzed Collagen

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Applies to products providing more than 2.8 g hydrolyzed collagen, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 March 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : DRASANVI

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line